Annual long term liabilities:
$671.41M+$23.33M(+3.60%)Summary
- As of today (July 1, 2025), AMPH annual total long term liabilities is $671.41 million, with the most recent change of +$23.33 million (+3.60%) on December 31, 2024.
- During the last 3 years, AMPH annual long term liabilities has risen by +$549.22 million (+449.45%).
- AMPH annual long term liabilities is now at all-time high.
Performance
AMPH Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$675.94M+$4.53M(+0.67%)Summary
- As of today (July 1, 2025), AMPH quarterly total long term liabilities is $675.94 million, with the most recent change of +$4.53 million (+0.67%) on March 31, 2025.
- Over the past year, AMPH quarterly long term liabilities has increased by +$29.15 million (+4.51%).
- AMPH quarterly long term liabilities is now -2.25% below its all-time high of $691.53 million, reached on September 30, 2023.
Performance
AMPH quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AMPH Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +3.6% | +4.5% |
3 y3 years | +449.4% | +452.5% |
5 y5 years | +867.0% | +922.8% |
AMPH Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +466.8% | -2.3% | +470.6% |
5 y | 5-year | at high | +867.0% | -2.3% | +950.7% |
alltime | all time | at high | +2979.7% | -2.3% | +3156.9% |
AMPH Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $675.94M(+0.7%) |
Dec 2024 | $671.41M(+3.6%) | $671.41M(+2.0%) |
Sep 2024 | - | $658.49M(+2.7%) |
Jun 2024 | - | $641.21M(-0.9%) |
Mar 2024 | - | $646.79M(-0.2%) |
Dec 2023 | $648.08M(+447.1%) | $648.08M(-6.3%) |
Sep 2023 | - | $691.53M(+28.6%) |
Jun 2023 | - | $537.75M(+350.2%) |
Mar 2023 | - | $119.44M(+0.8%) |
Dec 2022 | $118.47M(-3.1%) | $118.47M(-0.7%) |
Sep 2022 | - | $119.34M(-1.2%) |
Jun 2022 | - | $120.78M(-1.3%) |
Mar 2022 | - | $122.35M(+0.1%) |
Dec 2021 | $122.20M(+73.8%) | $122.20M(-1.1%) |
Sep 2021 | - | $123.51M(+67.0%) |
Jun 2021 | - | $73.97M(+9.3%) |
Mar 2021 | - | $67.68M(-3.7%) |
Dec 2020 | $70.31M(+1.3%) | $70.31M(+6.5%) |
Sep 2020 | - | $66.04M(+2.6%) |
Jun 2020 | - | $64.33M(-2.7%) |
Mar 2020 | - | $66.09M(-4.8%) |
Dec 2019 | $69.43M | $69.43M(+6.2%) |
Sep 2019 | - | $65.39M(-3.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $68.01M(+29.6%) |
Mar 2019 | - | $52.49M(+23.9%) |
Dec 2018 | $42.37M(-15.5%) | $42.37M(-0.9%) |
Sep 2018 | - | $42.75M(-1.8%) |
Jun 2018 | - | $43.53M(-13.2%) |
Mar 2018 | - | $50.14M(-0.0%) |
Dec 2017 | $50.14M(+32.4%) | $50.14M(+0.9%) |
Sep 2017 | - | $49.71M(+5.8%) |
Jun 2017 | - | $46.98M(+26.3%) |
Mar 2017 | - | $37.19M(-1.8%) |
Dec 2016 | $37.87M(+9.2%) | $37.87M(-4.3%) |
Sep 2016 | - | $39.55M(+11.5%) |
Jun 2016 | - | $35.45M(+5.8%) |
Mar 2016 | - | $33.50M(-3.4%) |
Dec 2015 | $34.67M(-22.8%) | $34.67M(-14.6%) |
Sep 2015 | - | $40.59M(-8.3%) |
Jun 2015 | - | $44.26M(-1.9%) |
Mar 2015 | - | $45.13M(+0.5%) |
Dec 2014 | $44.91M(+106.0%) | $44.91M(-18.2%) |
Sep 2014 | - | $54.93M(+3.2%) |
Jun 2014 | - | $53.24M(+156.6%) |
Mar 2014 | - | $20.75M(-4.8%) |
Dec 2013 | $21.80M(-9.0%) | $21.80M |
Dec 2012 | $23.96M | - |
FAQ
- What is Amphastar Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual long term liabilities year-on-year change?
- What is Amphastar Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Amphastar Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of AMPH is $671.41M
What is the all time high annual long term liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual total long term liabilities is $671.41M
What is Amphastar Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, AMPH annual total long term liabilities has changed by +$23.33M (+3.60%)
What is Amphastar Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AMPH is $675.94M
What is the all time high quarterly long term liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly total long term liabilities is $691.53M
What is Amphastar Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AMPH quarterly total long term liabilities has changed by +$29.15M (+4.51%)